Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial: Complete Statistical AnalysisIndependent statistical analysis of COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06547814).
- COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): Complete Statistical AnalysisIndependent statistical analysis of COVID-19, Chronic Adaptation and Response to Exercise (COVID-CARE): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04595773).
- COVID-AntibodyIndependent statistical analysis of Rapid SARS-CoV-2 IgG Antibody Testing in High Risk Healthcare Workers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04334876).
- COVIDX_EVCDAOIndependent statistical analysis of Clinical Validation of AI-Based System for Continuous Remote Monitoring of Patient Severity - Experts' Opinion: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- COViNOXIndependent statistical analysis of A Study to Assess Pulsed Inhaled Nitric Oxide vs Placebo in Subjects With Mild or Moderate COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- COVIPACT 2Independent statistical analysis of Psychological Care of Oncology Patients With Post-traumatic Stress in the Context of a COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- COZIIndependent statistical analysis of CBT-I or Zolpidem/Trazodone for Insomnia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04468776).
- CP-690-550 Ointment For Chronic Plaque Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of CP-690-550 Ointment For Chronic Plaque Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01246583).
- CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of CP-751,871 In Combination With Docetaxel In Advance Non-hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01653158).
- CPAP to Treat Cognitive Dysfunction in MS: Complete Statistical AnalysisIndependent statistical analysis of CPAP to Treat Cognitive Dysfunction in MS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02544373).
- CPCIndependent statistical analysis of Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CPEX-011Independent statistical analysis of Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CPIT001Independent statistical analysis of Check Point Inhibition After Autologous Stem Cell Transplantation in Patients at High Risk of Post Transplant Recurrence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old: Complete Statistical AnalysisIndependent statistical analysis of CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients: Complete Statistical AnalysisIndependent statistical analysis of CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients: primary endpoint results, effect estimate with confidence interval,…
- CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus: Complete Statistical AnalysisIndependent statistical analysis of CR845-CLIN3105: A Study to Evaluate the Safety and Effectiveness of CR845 in Hemodialysis Patients With Moderate-to-Severe Pruritus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Cranberry Effect on Urinary Tract Infections: Complete Statistical AnalysisIndependent statistical analysis of Cranberry Effect on Urinary Tract Infections: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02996981).
- Cranial Blocks for Postoperative Anesthesia: Complete Statistical AnalysisIndependent statistical analysis of Cranial Blocks for Postoperative Anesthesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04749797).
- Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.: Complete Statistical AnalysisIndependent statistical analysis of Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CRATUSIndependent statistical analysis of AllogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging FRAilTy Via IntravenoUS Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- CRCIndependent statistical analysis of Optimal Dose of Combination of Rocuronium and Cisatracurium: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02495038).
- CRC027Independent statistical analysis of Ofatumumab and High-dose Methylprednisolone in Patients With Chronic Lymphocytic Leukemia (CLL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Creative Arts Therapy (CAT) in the Center for Cancer and Blood Disorders: Complete Statistical AnalysisIndependent statistical analysis of Creative Arts Therapy (CAT) in the Center for Cancer and Blood Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CREDO 2Complete statistical analysis of the phase 3 CREDO 2 trial evaluating two olokizumab dosing regimens versus placebo and adalimumab in patients with active rheumatoid arthritis receiving methotrexate.
- CREDO 2Independent statistical analysis of Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate…
- CREMIndependent statistical analysis of Cognitive Remediation to Improve Mobility in Sedentary Seniors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02567227).
- CriSP-HSIndependent statistical analysis of Cold Stored Platelet in Hemorrhagic Shock: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04667468).
- CRISTALLOIndependent statistical analysis of A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT…
- CRITICALIndependent statistical analysis of Safety Study of Autologous Dendritic Cells Injected Into the Prostate After Cryoablation for Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- CROSSIndependent statistical analysis of Cesarean Trial of Staples vs. Sutures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01211600).
- Cross-vaccination Study of GSK Biologicals’ Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.: Complete Statistical AnalysisIndependent statistical analysis of Cross-vaccination Study of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine (GSK 1437173A) in Subjects Who Previously Received Placebo in ZOSTER-006 (NCT01165177) and ZOSTER-022 (NCT01165229) Studies.: primary endpoint results,…
- Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD: Complete Statistical AnalysisIndependent statistical analysis of Crossover Study to Assess the Efficacy of PT003 With and Without a Valved Holding Chamber in Subjects With Moderate to Severe COPD: primary endpoint results, effect estimate with…
- Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment: Complete Statistical AnalysisIndependent statistical analysis of Crossover Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- CROWN CORONAIndependent statistical analysis of CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04333732).
- CRP-TrackIndependent statistical analysis of Evaluation of the Predictive Nature of the Postoperative CRP on Postoperative Recovery in Patients Undergoing Colorectal Resection (CRP-Track): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CRPS-002Independent statistical analysis of Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1: primary endpoint results, effect estimate with confidence interval, sample-size…
- CRUSHIndependent statistical analysis of Connecting Resources for Urban Sexual Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02183909).
- CRYO-AFIndependent statistical analysis of Evaluation of the Cardioblate CryoFlex Surgical Ablation System in Longstanding Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy: Complete Statistical AnalysisIndependent statistical analysis of Cryoablation for Invasive Breast Carcinoma Following Neoadjuvant Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01388777).
- Cryoablation System FIM/CE Mark Study: Complete Statistical AnalysisIndependent statistical analysis of Cryoablation System FIM/CE Mark Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03723070).
- Cryoanalgesia vs. Epidural in the Nuss Procedure: Complete Statistical AnalysisIndependent statistical analysis of Cryoanalgesia vs. Epidural in the Nuss Procedure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02721017).
- Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis: Complete Statistical AnalysisIndependent statistical analysis of Cryotherapy in Treating Patients With Primary Stage I Non-Small Cell Lung Cancer or Lung Metastasis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- CS1543Independent statistical analysis of The FARAPULSE PersAFOne III Trial for the Treatment of Persistent Atrial Fibrillation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- CSISP-MENC1Independent statistical analysis of Immunogenicity of the Booster Dose of Two MenC Vaccines: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00392808).
- CSP# 585Independent statistical analysis of Gulf War Era Cohort and Biorepository: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01803854).
- CSPOTIndependent statistical analysis of Conduction System Pacing Optimized Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04905290).
- CSSIIndependent statistical analysis of Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI): primary endpoint results, effect estimate with confidence interval, sample-size planning…
- CT Guided Injection for Low Back Radiculopathy: A Randomized Clinical Trial: Complete Statistical AnalysisIndependent statistical analysis of CT Guided Injection for Low Back Radiculopathy: A Randomized Clinical Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- CTdeviceIndependent statistical analysis of Biomechanical Reconstruction of Three Different Hip Stem Designs in Hip Dysplasia Using a 3D CT-based Planning Software: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…